Overview (05 Nov 2026)
Cohance Lifesciences Ltd
COHANCE
INE03QK01018

Pharmaceuticals
Result will be declared on 06 Nov 2026
-1.45

Prev. Close
Previous Close
450.45
Current Close
449
Current High
458.2
Current Low
446.95
52 Week High
744.5
52 Week Low
267.85
Resistance 1
455.81
Resistance 2
462.63
Support 1
444.56
Support 2
433.31
Std Deviation
2.42%
DMA 200
409.12
DMA 50
452.23
DMA 20
454.58
Fundamentals and Ratios
Standalone
Trailing EPS
5.98
Forwad EPS
2.01
Trailing P/E
75.08
Forward P/E
223.01
PEG Ratio
-3.38
Mkt. Cap (Cr)
Market Cap (Cr)
17177.26
Total Debt(Cr)
Tot. Debt(Cr)
169.67
Reserve (Cr)
3873.03
Book Value
54.53
P/BV Ratio
8.23
ROCE(%)
5.00
ROE
6.00
Consolidated
Trailing EPS
4.69
Forwad EPS
0.85
Trailing P/E
95.74
Forward P/E
526.17
PEG Ratio
-4.09
Mkt. Cap (Cr)
Market Cap (Cr)
17177.26
Total Debt(Cr)
Tot. Debt(Cr)
400.49
Reserve (Cr)
3873.03
Book Value
102.23
P/BV Ratio
4.39
ROCE(%)
2.92
ROE
1.5000

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26567.55481.58497.79483.582030.5
Other Income12.25-0.796.1226.3013.1044.73
Total Income434.51566.76487.70524.09496.682075.23
Interest6.745.175.255.246.8022.46
Expenditure-477.38-493.81-417.41-403.37-417.54-1732.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-37.66-33.36-31.20-31.36-133.58
PBT-42.8756.4465.43120.7271.04313.63
Tax-2.32-21.88-18.14-26.43-18.47-84.92
Equity38.2638.260.000.0038.2638.26
OPM-9.879.9613.5924.2514.3015.11
Net Profit-45.1934.5647.2994.2952.57228.71
NPM-10.46.19.8218.9410.5811.02
EPS-0.630.91.242.461.385.98
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26619.12544.55555.57549.312268.55
Other Income12.25-1.846.1615.6014.1734.09
Total Income434.51617.28550.71571.17563.482302.64
Interest6.749.190.008.7610.1837.24
Expenditure-477.38-580.86-505.25-487.40-492.62-2066.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-51.230.00-44.02-45.14-187.33
PBT-42.8719.9140.6083.7762.76207.04
Tax-2.32-11.60-11.58-17.38-16.36-56.92
Equity38.2638.260.000.0038.2638.26
OPM-9.873.237.3714.6711.148.99
Net Profit-45.198.3129.0266.3946.4150.12
NPM-10.41.355.2711.628.236.52
EPS-0.630.5101.941.284.69
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings